Literature DB >> 30212053

Is the WHO disability grading system for leprosy related to the level of functional activity and social participation?

Vivian Taís Cunha de Souza, Walderi Monteiro Da Silva Júnior, Amélia Maria Ribeiro De Jesus, Daniela Teles De Oliveira, Helli Alkisti Raptis, Paulo Henrique Luiz De Freitas, Sheila Schneiberg.   

Abstract

To investigate the relationship between the WHO disability grading system for leprosy with the limitations to perform daily functional activities and the decrease in social participation in participants with leprosy. Participants with a diagnosis of leprosy were recruited at the dermatology ambulatory clinic of the University Hospital of Sergipe. In order to investigate the association of WHO disability grading system for leprosy with activities of daily living measured with the Screening Activity Limitation and Safety Awareness (SALSA) scale and with the social participation (P-scale), we performed an analysis with the Kruskal-Wallis test and the Spearman coefficient. Thirty-six patients diagnosed with leprosy participated in the study. Most of participants had mild to moderate daily activity limitations and 58% of participants did not have any restriction participation. The findings demonstrated that the WHO grading is associated with the level of activity (P < 0·0001; p = 0·58), but not with the level of participation (P <0·05; p = 0·27). Although the WHO grading system is used in Brazil and worldwide as an epidemiological indicator to explain the burden of leprosy, the results of this study demonstrated that in our sample the WHO grading system was not associated with participation. Participation is a complex construct with the influence of different psychosocial factors. In order to determine social participation damage of infectious diseases such as leprosy, it is necessary to develop new index of classification based on a broader definition of disability. Health professionals should consider the international classification of function and health (ICF) to develop such index.

Entities:  

Mesh:

Year:  2016        PMID: 30212053

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  4 in total

1.  Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia.

Authors:  Libardo J Gómez; Robin van Wijk; Lena van Selm; Alberto Rivera; Martha C Barbosa; Sandra Parisi; Wim H van Brakel; Jofren Arevalo; William Quintero; Mitzi Waltz; Karl Philipp Puchner
Journal:  Trans R Soc Trop Med Hyg       Date:  2020-07-01       Impact factor: 2.184

Review 2.  Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication?

Authors:  Luíse L Chaves; Yuri Patriota; José L Soares-Sobrinho; Alexandre C C Vieira; Sofia A Costa Lima; Salette Reis
Journal:  Pharmaceutics       Date:  2020-12-11       Impact factor: 6.321

3.  Functional activity limitation of leprosy cases in an endemic area in Indonesia and recommendations for integrated participation program in society.

Authors:  Sri Linuwih Menaldi; Melinda Harini; Nelfidayani Nelfidayani; Yunia Irawati; Steven Setiono; Luh Karunia Wahyuni; Tri Rahayu; Gitalisa Andayani; Dewi Friska; Boya Nugraha
Journal:  PLoS Negl Trop Dis       Date:  2022-08-19

4.  Characterization of New Leprosy Cases in Northeast of Iran within the Last 15 Years.

Authors:  Mahdis Ghavidel; Hamid Reza Bahrami Taghanaki; Amin Samiee; Kimiya Nourian; Kiarash Ghazvini
Journal:  Iran J Med Sci       Date:  2018-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.